Business Overview:
The March Group currently represents a highly profitable retail specialty pharmacy with 2010 sales projected to reach $11.6 million and EBITDA tracking $1.8 million. The full-service pharmacy dispenses high-margin specialty drugs such as biotech infusible, injectible and advanced oral medications to patients with chronic health conditions such as hemophilia, primary immune deficiencies (IVIG) and growth hormone deficiencies. Approximately 80% of the Company’s patients are receiving various hemophilia therapies. A new patient group with a five-year pharmacy benefit contract is expected to contribute to double-digit annual growth—projected to reach $15.5 in revenue and $2.7 million in EBITDA by 2013. Comprehensive patient management services using a team approach benefit both patients and physicians, resulting in high physician referral rates, high patient retention rates and exemplary customer service ratings with nearly 100 contracted payers. While the Company is nationally accredited and licensed in 48 states, historical sales efforts have been concentrated in only one U.S. region, translating into tremendous growth opportunities for a well-capitalized buyer.
For more information regarding this listing please contact us by completing the "Contact the Seller" form to the left. We look forward to hearing from you.
Property Features and Assets:
The Company is located in Tennessee, in close proximity to the Federal Express headquarters and main shipping terminal, which helps expedite delivery of critical and time sensitive medications to the patient when needed. The corporate offices and in-house pharmacy are located in a 3,100 square foot space and include a secured controlled-storage room that is monitored 24/7 by surveillance cameras and utilizes heat sensitive lighting and alarm systems that are automatically activated when the temperature changes.
Market Competition and Expansion:
Management expects to continue to capitalize on the Company’s excellent industry reputation for exceptional patient care, comprehensive “high-touch” services and unsurpassed customer support. Management envisions the following engines for potential growth:
Geographic expansion – With approximately 65 percent of sales attributed to one U.S. region, there is significant opportunity for growth by expanding the Company’s sales efforts into other regions of the country.
Increase sales and marketing efforts - The Company’s expansion plans will include qualified and motivated staff to optimize all sales efforts.
Web site development – The Company’s current Web site provides a wealth of information about this Company’s products and services, but enhancements are needed to supplement overall marketing efforts for greater visibility.
Expansion of current patient therapies – A new business development team will work with suppliers and patient advocacy groups to expand the Company’s targeted markets to include a higher concentration of IVIG and other profitable patient populations.
Reason for Selling:
Diversification of founder’s personal financial
Additional Details:
- The property is owned.
- The owner is willing to train/assist the new owner.
- This is not a homebased business opportunity.
- This is not a franchise resale opportunity.
- This is not a distressed business or bankruptcy situation.